Preclinical Drug Discovery Solutions
Tailored to Fit our Clients' Needs
Successful progression of small molecule drug discovery programs benefits from early integration of a multidisciplinary team of scientists. The founders of Nexus Discovery Advisors have over 20 combined years of experienced operating in this capacity as medicinal chemistry group leaders focused on hit ID, lead optimization and candidate selection. Whether you need guidance with overall project strategy and workflow, medicinal chemistry, CRO identification and management, patent and IP strategy or grant writing and fundraising, Nexus Discovery Advisors can help!
Nexus Discovery Advisors was founded with the passion to help biotechnology companies, academia and non-profit organizations navigate all aspects of early stage drug discovery and preclinical work. Through detailed diligence, we provide innovative solutions, strategic planning and guidance from project inception to proof of concept and candidate selection. The advantage of Nexus Discovery Advisors is our team first philosophy that delivers an unwavering commitment and drive to achieve our clients’ objectives.